Cognition Therapeutics(CGTX) - 2023 Q1 - Quarterly Report

Net cash used in investing activities for the three months ended March 31, 2023 and 2022 was less than $0.1 million and$0.1 million, respectively, related to a decreased purchase of fixed assets. Overall, the change in net cash used in investing activities was insignificant. Net cash used in financing activities was less than $0.1 million for the three months ended March 31, 2023, and net cash provided by financing activities was$0.1 million for the three months ended March 31, 2022. We have entered into ...